Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Drug Checking topic
No spam. Unsubscribe anytime.
Committee advances S 92 21, a contaminant‑tester program bill, and sends it to finance
Summary
S 92 21, sponsored in the record by Senator Ryan and described as creating a tester program for harmful contaminants in drugs, was moved, seconded and reported to the Finance Committee; the chair linked the measure to broader drug‑checking priorities.
A committee advanced S 92 21, described by the record as establishing a tester program for harmful contaminants — including referenced substances such as ametopidine and benzodiazepine contaminants — and reported the bill to the Finance Committee on May 19.
The committee identified Senator Ryan as the bill sponsor during the reading. After the bill was introduced, the chair praised Senator Ryan's measure and connected it to the broader need for drug‑checking authority: "this is, again, highlighting the the constant changing of the product that is out there," the chair said, adding that the bill underscores why the committee should pass related drug‑checking legislation. The committee member moved and a colleague seconded the bill; the chair called the voice vote and members answered "aye."
The meeting record contains positive remarks about the bill's relevance to changing drug supplies but does not include the bill text, funding details, or a recorded vote tally. The chair and committee framed the bill within the committee’s session priorities on addiction services and sustaining funding for those programs.
Next steps: S 92 21 was reported to the Finance Committee for fiscal and policy review; the transcript does not specify implementation timelines or budget figures.
